Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-21-032476

Chief Commercial Officer sold 17,000 shares at an average $134.78 ($2,291,221)

  • Chief Commercial Officer acquired 17,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

CRUTCHFIELD BRADFORD · Chief Commercial Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2021-05-12 Exercise or conversion : show line 1 in the form +17,000 $1.16 $19,720 51,608 D
2021-05-12 Sale : show line 2 in the form −5,123 $133.86 $685,759 46,485 D
2021-05-12 Sale : show line 3 in the form −7,875 $134.70 $1,060,759 38,610 D
2021-05-12 Sale : show line 4 in the form −2,702 $135.74 $366,781 35,908 D
2021-05-12 Sale : show line 5 in the form −1,200 $136.80 $164,164 34,708 D
2021-05-12 Sale : show line 6 in the form −100 $137.57 $13,757 34,608 D
Open-market sales · 17,000 sh · avg $134.78 · $2,291,221

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-05-12 Exercise or conversion : show line 7 in the form Stock Option (right to buy) −17,000 $1.16 2027-02-03 17,000 545,000 D
Loading xslF345X03/doc4.xml…